We are live on
!
Find out more
Harris Associates Portfolio holdings
AUM
$75.4B
1-Year Est. Return
14.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.55%
1 Year Est. Return
+14.46%
3 Year Est. Return
+51.56%
5 Year Est. Return
+71.24%
10 Year Est. Return
+347.3%
AUM
$54.4B
AUM Growth
-$89.3M
(-0.16%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
36.83%
Holding
134
New
6
Increased
38
Reduced
83
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$421M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$415M |
| 3 |
Diamondback Energy
FANG
|
+$306M |
| 4 |
Ryanair
RYAAY
|
+$240M |
| 5 |
Baidu
BIDU
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$922M |
| 2 |
Willis Towers Watson
WTW
|
+$344M |
| 3 |
DXC Technology
DXC
|
+$234M |
| 4 |
NOV
NOV
|
+$211M |
| 5 |
Liberty Global Class C
LBTYK
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.13% |
| 2 | Communication Services | 21% |
| 3 | Consumer Discretionary | 15.44% |
| 4 | Industrials | 10.76% |
| 5 | Technology | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
101
Permian Resources
PR
$19.6B
| $34.7M | 0.06% |
4,572,136
+287,122
| +7% | +$2.55M |
|
102
Masco
MAS
$14.3B
| $33.6M | 0.06% |
855,320
+221,790
| +35% | +$8.55M |
|
103
Equifax
EFX
$20.8B
| $29.6M | 0.05% |
219,012
-18,170
| -8% | -$2.28M |
|
104
CarMax
KMX
$8.98B
| $25.8M | 0.05% |
296,926
-81,910
| -22% | -$6.41M |
|
105
Dover
DOV
$26B
| $23.7M | 0.04% |
236,042
-34,400
| -13% | -$3.3M |
|
106
Arcosa
ACA
$7.14B
| $23.1M | 0.04% |
613,231
+9,652
| +2% | +$330K |
|
|
107
DXC Technology
DXC
$1.86B
| $22M | 0.04% |
398,576
-4,049,971
| -91% | -$234M |
|
|
SLCA
108
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $18.8M | 0.03% |
1,467,900
-173,300
| -11% | -$2.36M |
|
109
Axalta
AXTA
$7.66B
| $15M | 0.03% |
503,911
-83,710
| -14% | -$2.22M |
|
110
Zimmer Biomet
ZBH
$18.7B
| $10.1M | 0.02% |
88,670
-1,133
| -1% | -$133K |
|
111
Nasdaq
NDAQ
$54.2B
| $10.1M | 0.02% |
+313,875
| New | +$9.62M |
|
112
Qorvo
QRVO
$9.07B
| $9.26M | 0.02% |
138,984
-6,625
| -5% | -$460K |
|
113
WPP
WPP
$5.46B
| $9.2M | 0.02% |
146,300
-2,300
| -2% | -$139K |
|
|
114
CALL
DXC Technology
DXC
$1.86B
| $5.99M | 0.01% |
+38,000
| New | +$2.2M |
|
115
Bristol-Myers Squibb
BMY
$136B
| $5.53M | 0.01% |
121,824
-734,850
| -86% | -$34.2M |
|
116
JPMorgan Chase
JPM
$953B
| $4.27M | 0.01% |
38,216
-936
| -2% | -$103K |
|
|
117
CALL
NOV
NOV
$7.63B
| $2.56M | ﹤0.01% |
+57,000
| New | +$1.38M |
|
118
SLB Ltd
SLB
$85.3B
| $1.92M | ﹤0.01% |
48,250
+12,400
| +35% | +$500K |
|
119
Fortune Brands Innovations
FBIN
$5.15B
| $1.67M | ﹤0.01% |
34,217
-2,954
| -8% | -$131K |
|
120
ManpowerGroup
MAN
$2.88B
| $1.24M | ﹤0.01% |
12,815
-1,375
| -10% | -$125K |
|
|
ETFC
121
DELISTED
E*Trade Financial Corporation
ETFC
| $1.21M | ﹤0.01% |
27,200
+375
| +1% | +$17.9K |
|
122
Baker Hughes
BKR
$63B
| $779K | ﹤0.01% |
31,632
-12,500
| -28% | -$301K |
|
123
Unilever
UL
$138B
| $682K | ﹤0.01% |
9,778
-114,608
| -92% | -$7.78M |
|
124
US Bancorp
USB
$98.7B
| $560K | ﹤0.01% |
10,691
-5,572
| -34% | -$287K |
|
125
Brunswick
BC
$4.82B
| $525K | ﹤0.01% |
11,450
-1,475
| -11% | -$71.2K |
|
Similar funds
BC
Harris Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Harris Associates held 134 positions worth $54.4B, down 0.16% from $54.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Harris Associates's Q2 2019 filing shows 6 new, 38 increased, 83 reduced and 4 closed positions. Its largest new stake was CONCHO RESOURCES INC.: 3,900,576 shares worth $402M. The largest sale was Anadarko Petroleum, an estimated $922M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Harris Associates's largest Q2 2019 buy was CONCHO RESOURCES INC.: 3,900,576 shares worth $402M.
- Harris Associates added most to Regeneron Pharmaceuticals in Q2 2019, an estimated $415M increase.
- Harris Associates's biggest Q2 2019 reduction was Anadarko Petroleum, cutting an estimated $922M.
- Harris Associates fully exited Usg in Q2 2019, selling an estimated $70.8M.
- Harris Associates's ten largest holdings make up 37% of its $54.4B portfolio in Q2 2019.
- Harris Associates opened 6 new positions and closed 4 in Q2 2019.
- Harris Associates's portfolio value fell 0.16% quarter-over-quarter to $54.4B.
Based on Harris Associates's 13F filing for Q2 2019, filed 14 Aug 2019.